Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
28.00
USD |
NASDAQ |
Mar 06, 16:00
Ambrx Biopharma Market Cap
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| March 06, 2024 | 1.768B |
| March 05, 2024 | 1.767B |
| March 04, 2024 | 1.766B |
| March 01, 2024 | 1.767B |
| February 29, 2024 | 1.764B |
| February 28, 2024 | 1.764B |
| February 27, 2024 | 1.763B |
| February 26, 2024 | 1.764B |
| February 23, 2024 | 1.764B |
| February 22, 2024 | 1.764B |
| February 21, 2024 | 1.749B |
| February 20, 2024 | 1.752B |
| February 16, 2024 | 1.754B |
| February 15, 2024 | 1.752B |
| February 14, 2024 | 1.754B |
| February 13, 2024 | 1.754B |
| February 12, 2024 | 1.755B |
| February 09, 2024 | 1.755B |
| February 08, 2024 | 1.755B |
| February 07, 2024 | 1.755B |
| February 06, 2024 | 1.754B |
| February 05, 2024 | 1.754B |
| February 02, 2024 | 1.755B |
| February 01, 2024 | 1.754B |
| January 31, 2024 | 1.756B |
| Date | Value |
|---|---|
| January 30, 2024 | 1.755B |
| January 29, 2024 | 1.755B |
| January 26, 2024 | 1.753B |
| January 25, 2024 | 1.754B |
| January 24, 2024 | 1.746B |
| January 23, 2024 | 1.752B |
| January 22, 2024 | 1.756B |
| January 19, 2024 | 1.746B |
| January 18, 2024 | 1.742B |
| January 17, 2024 | 1.742B |
| January 16, 2024 | 1.748B |
| January 12, 2024 | 1.766B |
| January 11, 2024 | 1.774B |
| January 10, 2024 | 1.762B |
| January 09, 2024 | 1.740B |
| January 08, 2024 | 1.735B |
| January 05, 2024 | 860.74M |
| January 04, 2024 | 843.69M |
| January 03, 2024 | 858.21M |
| January 02, 2024 | 855.05M |
| December 29, 2023 | 899.26M |
| December 28, 2023 | 915.68M |
| December 27, 2023 | 928.31M |
| December 26, 2023 | 918.20M |
| December 22, 2023 | 901.78M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 574.02B |
| Axonics Inc (DELISTED) | -- |
| Harpoon Therapeutics Inc (DELISTED) | -- |
| Merck & Co., Inc. | 294.12B |
| RayzeBio inc (DELISTED) | -- |
Market Cap Related Metrics
| PS Ratio | 1776.23 |
| Price to Book Value | 7.292 |
| Earnings Yield | -1.82% |